2 results
Approved WMORecruiting
Primary Objective: To determine the safety and feasibility of pre-operative immunotherapy in CRC. Additional Primary Objective for the expanded the MSI cohort: To assess efficacy of neoadjuvant ipilimumab plus nivolumab in terms of disease-free…
Approved WMOWill not start
The objective of this study is to evaluate the safety and performance of the DaVingi* TR System for the treatment of patients with functional tricuspid regurgitation within its intended use.The study will:• Evaluate the safety and feasibility of…